tiprankstipranks
4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Income Statement

Compare
350 Followers

4D Molecular Therapeutics Income Statement

Last quarter (Q4 2024), 4D Molecular Therapeutics's total revenue was $1.00K, a decrease of -105.26% from the same quarter last year. In Q4, 4D Molecular Therapeutics's net income was $-49.67M. See 4D Molecular Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 37.00K$ 20.72M$ 3.13M$ 18.04M$ 13.61M
Gross Profit
$ 37.00K$ -76.37M$ -751.00K$ 15.02M$ -39.43M
Operating Expenses
$ 187.88M$ 133.59M$ 113.16M$ 89.37M$ 70.28M
Depreciation and Amortization
$ 0.00$ 5.75M$ 3.88M$ 3.02M$ 1.44M
EBITDA
$ -187.84M$ -107.12M$ -106.15M$ -68.31M$ -55.22M
Operating Income
$ -187.84M$ -112.87M$ -110.03M$ -71.33M$ -56.66M
Other Income/Expenses
$ 26.97M$ 12.03M$ 2.54M$ 16.00K$ -29.00K
Pretax Income
$ -160.87M$ -100.84M$ -107.49M$ -71.32M$ -56.69M
Net Income
$ -160.87M$ -100.84M$ -101.08M$ -68.30M$ -56.54M
Per Share Metrics
Basic EPS
$ -2.98$ -2.58$ -3.12$ -2.46$ -2.12
Diluted EPS
$ -2.98$ -2.58$ -3.12$ -2.46$ -2.12
Weighted Average Shares Outstanding
53.94M 39.13M 32.35M 27.73M 26.68M
Weighted Average Shares Outstanding (Diluted)
53.94M 39.13M 32.35M 27.73M 26.68M
Currency in USD

4D Molecular Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis